Literature DB >> 15520479

Immunology of tuberculosis.

Alamelu Raja1.   

Abstract

Tuberculosis is a major health problem throughout the world causing large number of deaths, more than that from any other single infectious disease. The review attempts to summarize the information available on host immune response to Mycobacterium tuberculosis. Since the main route of entry of the causative agent is the respiratory route, alveolar macrophages are the important cell types, which combat the pathogen. Various aspects of macrophage-mycobacterium interactions and the role of macrophage in host response such as binding of M. tuberculosis to macrophages via surface receptors, phagosome-lysosome fusion, mycobacterial growth inhibition/killing through free radical based mechanisms such as reactive oxygen and nitrogen intermediates; cytokine-mediated mechanisms; recruitment of accessory immune cells for local inflammatory response and presentation of antigens to T cells for development of acquired immunity have been described. The role of macrophage apoptosis in containing the growth of the bacilli is also discussed. The role of other components of innate immune response such as natural resistance associated macrophage protein (Nramp), neutrophils, and natural killer cells has been discussed. The specific acquired immune response through CD4 T cells, mainly responsible for protective Th1 cytokines and through CD8 cells bringing about cytotoxicity, also has been described. The role of CD-1 restricted CD8(+) T cells and non-MHC restricted gamma/deltaT cells has been described although it is incompletely understood at the present time. Humoral immune response is seen though not implicated in protection. The value of cytokine therapy has also been reviewed. Influence of the host human leucocyte antigens (HLA) on the susceptibility to disease is discussed. Mycobacteria are endowed with mechanisms through which they can evade the onslaught of host defense response. These mechanisms are discussed including diminishing the ability of antigen presenting cells to present antigens to CD4(+) T cells; production of suppressive cytokines; escape from fused phagosomes and inducing T cell apoptosis. The review brings out the complexity of the host-pathogen interaction and underlines the importance of identifying the mechanisms involved in protection, in order to design vaccine strategies and find out surrogate markers to be measured as in vitro correlate of protective immunity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520479

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  69 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

2.  In vitro levels of interleukin 10 (IL-10) and IL-12 in response to a recombinant 32-kilodalton antigen of Mycobacterium bovis BCG after treatment for tuberculosis.

Authors:  V Hari Sai Priya; B Anuradha; Suman Latha Gaddam; Seyed E Hasnain; K J R Murthy; Vijaya Lakshmi Valluri
Journal:  Clin Vaccine Immunol       Date:  2008-11-05

3.  Synthetic lipopeptide MALP-2 inhibits intracellular growth of Mycobacterium bovis BCG in alveolar macrophages-preliminary data.

Authors:  Grit Jörgens; Franz-Christoph Bange; Peter F Mühlradt; Reinhard Pabst; Ulrich A Maus; Thomas Tschernig
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

Review 4.  Clinical immunology and multiplex biomarkers of human tuberculosis.

Authors:  Gerhard Walzl; Mariëlle C Haks; Simone A Joosten; Léanie Kleynhans; Katharina Ronacher; Tom H M Ottenhoff
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-04       Impact factor: 6.915

5.  Role of QuantiFERON-TB Gold antigen-specific IL-1β in diagnosis of active tuberculosis.

Authors:  Maddineni Prabhavathi; Basirudeen Syed Ahamed Kabeer; Anbarasu Deenadayalan; Alamelu Raja
Journal:  Med Microbiol Immunol       Date:  2014-12-11       Impact factor: 3.402

6.  Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection.

Authors:  R C Chukwuanukwu; C C Onyenekwe; L Martinez-Pomares; R Flynn; S Singh; G I Amilo; N R Agbakoba; J O Okoye
Journal:  Clin Exp Immunol       Date:  2016-10-21       Impact factor: 4.330

7.  Evaluation of memory immune response to mycobacterium extract among household contact of tuberculosis cases.

Authors:  Y V N Cavalcanti; V R A Pereira; L C Reis; A L G Ramos; C F Luna; E J M Nascimento; N Lucena-Silva
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

8.  High-throughput high-resolution class I HLA genotyping in East Africa.

Authors:  Rebecca N Koehler; Anne M Walsh; Eric E Sanders-Buell; Leigh Anne Eller; Michael Eller; Jeffrey R Currier; Christian T Bautista; Fred Wabwire-Mangen; Michael Hoelscher; Leonard Maboko; Jerome Kim; Nelson L Michael; Merlin L Robb; Francine E McCutchan; Gustavo H Kijak
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

9.  Zinc and vitamin A supplementation fails to reduce sputum conversion time in severely malnourished pulmonary tuberculosis patients in Indonesia.

Authors:  Trevino A Pakasi; Elvina Karyadi; Ni Made Desy Suratih; Michael Salean; Nining Darmawidjaja; Hans Bor; Koos van der Velden; Wil M V Dolmans; Jos W M van der Meer
Journal:  Nutr J       Date:  2010-09-28       Impact factor: 3.271

10.  A study of serum malondialdehyde and cytokine in tuberculosis patients.

Authors:  Rashmi Kulkarni; Ajit Deshpande; Ravi Saxena; Kiran Saxena
Journal:  J Clin Diagn Res       Date:  2013-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.